References
- Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease study. Lancet 1997; 349: 1269–1276
- Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, Redgrave JN, Bull LM, Welch SJ, Cuthbertson FC, et al. Population-based study of event rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005; 366: 1773–1783, for the Oxford Vascular Study
- Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: A cohort study. BMJ 1996; 313: 1440–1444
- Leng GC, Lee AJ, Fowkes FG, Whiteman M, Dunbar J, Housley E, Ruckley CV. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25: 1172–1181
- Jönnsson B, Skau T. Ankle-brachial index and mortality in a cohort of questionnaire recorded leg pain on walking. Eur J Vasc Endovasc Surg 2002; 24: 405–410
- Ward AS, Porter N, Preston FE, Morris-Jones W. Platelet aggregation in patients with peripheral vascular disease. Atherosclerosis 1978; 29: 63–68
- Reininger CB, Boeger CA, Steckmeier B, Spannagl M, Scweiberer L. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results. Int Angiol 1999; 18: 163–170
- Robless PA, Okonko D, Lintott P, Mansfield AO, Mikhailidis DP, Stansby GP. Increased platelet aggregation and activation in peripheral arterial disease. Eur J Vasc Endovasc Surg 2003; 25: 16–22
- Robless PA, Okonko D, Mikhailidis DP, Stansby GP. Dextran 40 reduces in vitro platelet aggregation in peripheral arterial disease. Platelets 2004; 15: 215–222
- Jagroop IA, Matsagas MI, Geroulakos G, Mikhailidis DP. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease. Platelets 2004; 15: 117–125
- Saniabadi AR, Lowe GD, Barbenel JC, Forbes CD. A comparison of spontaneous platelet aggregation in whole blood and platelet rich plasma: Additional evidence for the role of ADP. Thromb Haemost 1984; 51: 115–118
- Saniabadi AR, Lowe GD, Madhok R, Spowart K, Shaw B, Barbenel JC, Forbes CD. Red blood cells mediate spontaneous aggregation of platelets in whole blood. Atherosclerosis 1987; 66: 175–180
- Menys VC, Belcher PR, Noble MI, Evans RD, Drossos GE, Pillai R, Westaby S. Macroaggregation of platelets in plasma, as distinct from microaggregation in whole blood (and plasma), as determined using optical aggregometry and platelet counting respectively, is specifically impaired following cardiopulmonary bypass in man. Thromb Haemost 1994; 72: 511–518
- Muriithi EW, Belcher PR, Day SP, Menys VC, Wheatley DJ. Heparin-induced platelet dysfunction and cardiopulmonary bypass. Ann Thorac Surg 2000; 69: 1827–1832
- Smout JD, Mikhailidis DP, Shenton BK, Stansby G. Combination antiplatelet therapy in patients with peripheral vascular bypass grafts. Clin Appl Thromb Hemost 2004; 10: 9–18
- Cannon CP. Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE Trial). Am J Cardiol 2002; 90: 760–762
- Aronow WS. Management of peripheral arterial disease. Cardiology in Review 2005; 13: 61–68
- Perneger T. What's wrong with Bonferroni adjustments?. BMJ 1998; 316: 1236–1238
- Menys VC, Belcher PR, Noble MI, Drossos GE, Pillai R, Westaby S. Impaired platelet aggregation in cardiopulmonary bypass in man: Enhancement of collagen-induced aggregation in whole blood and plasma by adrenaline ex vivo. Clin Sci 1995; 88: 269–275
- Armstrong R, May JA, Losche W, Heptinstall S. Factors that may contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood. Thromb Haemost 1995; 73: 297–303